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Abstract 
To develop a computer-aided diagnostic scheme by using an artificial neural network (ANN) combined with tumor 
markers for diagnosis of hepatic carcinoma (HCC) as a clinical assistant method. 140 serum samples (50 malignant, 
40 benign and 50 normal) were analyzed for -fetoprotein (AFP), carbohydrate antigen 125 (CA125), 
carcinoembryonic antigen (CEA), sialic acid (SA) and calcium (Ca). The five tumor marker values were then used as 
ANN inputs data. The result of ANN was compared with that of discriminant analysis by receiver operating 
characteristic (ROC) curve (AUC) analysis. The diagnostic accuracy of ANN and discriminant analysis among all 
samples of the test group was 95.5% and 79.3%, respectively. Analysis of multiple tumor markers based on ANN 
may be a better choice than the traditional statistical methods for differentiating HCC from benign or normal. 
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I.  Introduction  
HCC is one of the most common cancers in the world, and its mortality rate is next to cancer of the 
stomach and esophagus and resides the 3rd [1]. For a long time, HCC has been the second leading cause 
of cancer death in china. In recently years, the incidence and mortality rate have been increasing [2]. For 
the lack of typical symptoms of HCC in early stage, it is easy to neglect, and easy to confuse with other 
gastrointestinal diseases. The diagnosis of HCC usually occurs at later stages in the disease when there 
are few effective treatment options and the prognosis for patients with HCC is very poor. Currently 
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serum AFP combined with ultrasound imaging is applied to achieve the monitoring of high-risk groups in 
clinic. HCC can be diagnosed in sub-clinical stage. But now people rely too much on liver cancer 
diagnostic imaging. AFP is a specific indicator for diagnosis of HCC, but the specificity of its individual 
value is not adequate for effective screening. Related literature reported that the positive rate of AFP was 
from 60% to 80% [3].There is also defective in ultrasound. Multiple serum markers might be utilized to 
improve sensitivity. Over the years, a large number of markers for HCC have been reported to 
complement AFP [4]. However, tumor markers cannot solve the problem because it contains multi-
parameter which cannot be efficiently analyzed by general statistics analysis methods. Methods based on 
ANN appear to be suited for this task.   
ANN analysis as a statistical modeling tool has demonstrated the ability to assimilate information from 
multiple sources and detect subtle and complex patterns. It is a statistical model whose mathematical    
structure reproduces the biological organization of neural cells for simulation of the learning dynamics of 
the brain. This model solves the problems of uncertain or ambiguous medical information more 
effectively. There have been a large number of reports on the use of ANN for clinical diagnosis [5]. The 
ANN based computer-aided diagnostic scheme of HCC has become one of the most active parts in the 
recent medical research. Application of intelligent diagnosis system based on the ANN is used to 
automatic detection and classification for cancer and to improve the accuracy of detection and 
classification [6]. 
In this paper, chemiluminescence immunoassay and spectrophotometry were separately used to detect 
the serum -fetoprotein (AFP), carbohydrate antigen 125 (CA125), carcinoembryonic Antigen (CEA), 
sialic acid (SA) and calcium (Ca) in three groups. ANN technology can be applied to extract effective 
features and improve the diagnostic accuracy of HCC.  
2. Subject and Methods 
2.1Study population 
A total of 140 serum samples were obtained from the First Affiliated Hospital of Zhengzhou 
University. The collection included 50 specimens from patients with HCC, 40 specimens from patients 
with benign conditions and 50 normal individuals. All benign and malignant patients were confirmed by 
pathology, and normal subjects were confirmed by checkup centers. The 50 patients with HCC (age 
range was 25~81 years old, average 55.73±12.30 years, 41of males, 9 of females) were obtained 
including 42 patients with primary HCC and 8 patients with secondary HCC (34 hepatocellular 
carcinoma, 10 intrahepatic cholangiocarcinoma and 6 mixed hepatocarcinoma ). The 40 patients with 
benign liver disease (age range was 26~70 years old, average 46.15±12.45 years, 26 of males, 14 of 
females) were enrolled. There are 50 health cases in normal group (age range was 23~60 years old, 
average 42.18±11.45 years, 23 of males and 27 of females). 
2.2 Sample preparation and tumor marker measurements 
All blood samples were collected in the fasting state, laid at room temperature for 30 minutes and 
centrifuged for 3 minutes at 3000 r/min. the abstracted serum samples were stored at 80 °C and thawed 
immediately prior to assay. AFP, CA125 and CEA were detected by chemiluminescence immunoassay. 
SA was determined by spectrophotometry. Ca was detected by calcium assay kit (Azo-end method of 
arsenic ). 
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2.3  ANN model derivation 
Three-layer, feed-forward ANN with back-propagation (BP) algorithm were implemented. The 140 
samples were allocated randomly into training set (100 samples) and test set (40 samples). The model 
was developed by training set. Then, the samples of test set were used to validate the quality of model. 
The training and testing of the ANN were performed by means of Sigmoid transfer function. The five 
tumor marker values in 35 cases with HCC, 30 patients with benign liver disease and 35 normal cases 
were used as input data. Network parameter settings were 5 nodes as input layer, 15 nodes as hidden 
layer, 1 node as output layer, 0.001 as target error, 0.7 as learning rate, 0.95 as momentum factor. The 
value equal to 0.9 was HCC, equal to 0.5 was benign and equal to 0.1 was normal. 
The marker values were preprocessed numerically before being used as inputs to the ANN.  It 
involved logarithmic transformation and a “physiologically based” normalization step. In this step, 
marker values were truncated to within a range most relevant to the differentiation of patients before 
normalization. 
2.4  Data Analysis 
The final results of test set which were forecasted by BP network compared with the results of 
discriminant analysis which was according to SPSS12.0 by using of AUC. The level of test was 0.05.  
3. Results 
3.1 The detecting results of serum tumor marker 
In table I, descriptive statistics of the five tumor markers were listed. The concentration value of SA 
followed Gaussian distributions and was expressed by Mean±SD, while other tumor markers showed 
skew distribution and was expressed by median and interquartile range. 
3.2  Discriminant analysis model and Prediction Results 
In this study, the variables available for inclusion in the model were AFP, CEA, CA125, SA and Ca. 
The discriminant function was derived based on the known measurements (The expected value in three 
groups was 1, 2 and 3) and the characteristic of variables, then the discriminant functions were used to 
decide which class the cases belonged to. The accurate rate was obtained through comparing the 
classification of original data and the classification of discriminant function. In the process of modeling, 
the log-in not systematic full-model method and fisher function factor were chose. The results of 
discriminant analysis were as follows.  
In table , the first three lines were the number of results judged by discriminant functions, while the 
rest three lines were the corresponding percentage. The accurate rate was 79.3% for three groups by 
discriminant analysis model. 
3.3  Development of artificial neural network model 
BP neural network was applied to develop the diagnostic model by training set according to the setting 
error. The expected results were achieved after 3000 iterations and then stopped the training. Then the 
model was validated by test set. The sensitivity of HCC was 93.3%, the specificity was 96.0%, the 
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accuracy was 95.5%, the positive predictive value (PPV) was 93.75% and the negative predictive value 
(NPV) was 96.2%.   
3.4 Comparisons of Discriminant Analysis and ANN 
Table  shows the prediction results contrast of BP network and discriminant analysis. Figure 1 
shows the ROC curves. The accuracy rates of prediction according to the ANN and discriminant analysis 
equation were 94.3% and 79.3%, the area under the ROC curve were 0.986(95%CI: 0.968~1.005) and 
0.842(95%CI: 0.774~0.0.910), respectively.  
TABLE I Testing results for AFP, CEA, CA125, SA, and Ca    
a median , b interquartile range, 
m P<0.05, n P>0.05. 
 
 
 
 
TABLE Results of discriminant 
analysis
Original group 
Predicted Group Membership 
Total Hepato 
carcinoma Benign Normal 
Count HCC    23      24 3 50 
 Benign   1      39 0 40 
 Normal   0     1 49 50 
% HCC   46.0    48.0 6.0 100.0 
 Benign    2.5    97.5 .0 100.0 
 Normal    0.0   2.0 98.0 100.0 
Table  Comparison of results in test set by BP and discriminant analysis 
Assessment index ANN model Discriminant 
analysis  
Sensitivity (%)a  96.0 46.0 
Specificity (%)a  98.9 98.9 
Accuracy (%) 94.3 79.3 
PPV (%) 98.0 95.8 
NPV (%) 97.8 76.7 
AUC 0.986b  0.842 
95% CI 0.968~1.005 0.774~0.910 
aThe sensitivity and specificity were calculated according to HCC,  
bP<0.05 for difference in area under ROC curve between ANN and discriminant analysis. 
Group n AFP (μg/L) 
CA125 
(U/ml) 
CEA 
(ng/ml) 
SA 
(mg/L) 
Ca 
(mg/L) 
Normal 50 1.80
a 
1.76b 
10.90 
5.40 
9.45 
2.78 
805.44 
93.10 
119.84 
30.76 
Benign 40 0.86 1.39 
6.45 
3.89 
0.51 
0.55 
829.17 
97.32 
97.04 
5.09 
HCC 50 22.86
m 
439.30 
39.18m 
49.82 
0.32n 
0.61 
833.96
148.73n  
103.40 
37.44m 
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Fig. 1 ROC curves of BP and Discriminant analysis  
4. Discussion 
4.1 The diagnostic value of HCC with tumor markers  
AFP was first identified in human fetus serum by Bergstralad and Czar in 1956 [7]. It is a molecular 
70,000 glycoprotein, produced at high levels by the fetal liver, transcriptionally repressed after birth. AFP 
is a specific indicator and is the most common serological marker used in HCC [8]. AFP level of 20μg/L 
is considered as a level that prompts further testing. A systematic review reported that sensitivity of AFP 
levels higher than 20μg/L ranged from 41% to 65%, while specificity ranged from 80% to 94% [9]. The 
positive rate of AFP was 60% in this research. This indicated that the sensitivity and specificity of single 
marker for diagnosis of primary HCC were not high. It was also reported that 40% of patients with early 
primary HCC and 15%~20% of those with advanced primary HCC, serum AFP were normal. CA 125, a 
high molecular weight mucin, was first detected with a radioimmunoassay in patients with advanced 
ovarian cancer [10]. Later, it was found in a wide variety of tumors and was regarded as a relatively 
broad spectrum tumor marker. Increased serum CA125 levels are correlated with the severity of liver 
damage. By ELISA, the positive rate of AFP was 76.0%, the positive rate of CA125 in all patients and 
AFP positive group was 68.7% and 42.9% [11]. The positive rate of CA125 tested by 
electrochemiluminescence assay was 59.57% [12]. In short, CA125 is one of the indexes which reflect 
the severity of liver damage in cirrhosis patients, and it is also a sign that cirrhosis produce canceration. 
CEA was a nonspecific tumor-associated antigens which was first extracted from colon cancer by Gold 
and Freedom Man. Previous studies reported that CEA was a tumor marker of colon carcinoma. Later 
studies revealed CEA still express highly in liver and gastric cancer, and had higher sensitivity for 
malignant tumor of enteron developed from the embryonic endodermal layer. The rate of positive 
diagnosis of HCC was over 50% [13]. SA is a vital component of glycoprotein and glycolipids in cell 
membranes. The serum concentration of SA is at a normal level when cell metabolism is normal. If it is 
abnormal metabolism, especially advanced malignant tumor, the serum SA level is significantly elevated. 
A series of reports suggested that serum SA could be regarded as a sensitive marker in early diagnosing 
of HCC. It has been reported that the sensitivity, specificity, PPV, NPV and accuracy of SA assay to 
diagnose HCC were 70%, 88.3%, 75%, 85.5% and 82.2%, respectively [14]. But it is not a specific 
 Shanjuan Tan et al. /  Physics Procedia  33 ( 2012 )  172 – 178 177
 
marker for HCC, and should be combined with other tumor markers for identifying HCC. Liver plays an 
adjustment role in Ca metabolism. The serum Ca level was reduced after serious disease and cancer of 
the liver from lack of Ca uptake as a result of the decreased process of vitamin D hydroxylation. It was 
reported that the level of calcitonin was increased in Patients with HCC and the level decreased after 
operation. This showed that HCC could produce calcitonin. Experiment showed that the serum Ca, 
especially free Ca, was correlated to the severity of liver dysfunction [15].   
According to this study, AFP was the most specific indicator in these five tumor markers, and this 
showed that it was a relatively sensitive and specific marker in diagnosis of HCC. Moreover, CA125 and 
Ca were the relative specific indicators of HCC. Combined detection of AFP, Ca and CA125 might be 
useful for assisted diagnosis of HCC. The sensitivity and specificity of other two indicators were not 
elevated and were useful mainly in the tumor markers with union tests.   
4.2 The prediction of HCC by ANN model 
With the thorough study of ANN and the swift development of computer application technology, the 
theory of ANN gradually became mature, and in recent years has been used in many fields. It also 
gradually obtained the development in the application of medical field. ANN is different from traditional 
statistics. According to ANN, the basic data may not be followed Gaussian distribution, and has certain 
fault tolerance. These advantages bring considerable convenience to the popularity of ANN. 
Conventional methods combined with multiple markers might be utilized to improve sensitivity, but 
specificity has inevitably been reduced. ANN might improve sensitivity using multiple markers without 
sacrificing specificity.   
The established ANN model in this article had sensitivity of 93.3%, specificity of 96.0%, accuracy of 
95.5%, PPV of 93.75% and NPV of 96.2%. The results of this study were superior to detection of tumor 
marker alone and combined detection of tumor markers [16-19]. Moreover, the ANN model 
accomplished not only the differential diagnosis of HCC with benign and normal but also the differential 
diagnosis of benign disease and normal. This is a matter of the utmost importance to screening the high 
risk people. These results indicated that ANN in combination with multiple markers can realize the 
assisted diagnosis of liver cancer.  
4.3 Comparisons of ANN Model and Discriminant analysis 
The sensitivity, specificity, accuracy, PPV and NPV of ANN and discriminant analysis model were 
evaluated. The specificity and PPV seemed to be equal between the two models while the others were 
obviously different. The AUC was used to compare ANN model and discriminant analysis in predicting 
accuracy of HCC. The AUC of ANN model was higher than discriminant analysis, there was statistical 
significance.  
Based on the ANN, a classification model of HCC was established in this paper, whose effect was 
superior to traditional discriminant analysis. The reason is that discriminant analysis processed 
parameters by use of linear combination. The basic data must subject to the normal-distribution condition 
and have the same covariance matrix. However, in practical applications, many data are unable to meet 
those conditions. ANN is suitable to solve complex or non-linear problem and has a powerful of learning 
and memory, association and other functions, which adapt to the assisted diagnosis and data analysis 
better. 
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